CELEX: 62020TB0162
Language: en
Date: 2020-08-12 00:00:00
Title: Case T-162/20 R: Order of the President of the General Court of 12 August 2020 — Indofil Industries (Netherlands) v EFSA (Interim relief — Plant protection products — Regulation (EC) No 1107/2009 — Publication of the conclusion on the review conducted by EFSA regarding the reconsideration of the approval of the active substance mancozeb — Request for certain passages to be treated as confidential — Refusal to grant confidential treatment — Application for interim measures — No prima facie case)

3.11.2020   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 371/15
            
         
      Order of the President of the General Court of 12 August 2020 — Indofil Industries (Netherlands) v EFSA
      (Case T-162/20 R)
      (Interim relief - Plant protection products - Regulation (EC) No 1107/2009 - Publication of the conclusion on the review conducted by EFSA regarding the reconsideration of the approval of the active substance mancozeb - Request for certain passages to be treated as confidential - Refusal to grant confidential treatment - Application for interim measures - No prima facie case)
      (2020/C 371/17)
      Language of the case: English
      
         Parties
      
      
         Applicant: Indofil Industries (Netherlands) BV (Amsterdam, Netherlands) (represented by: C. Mereu and S. Englebert, lawyers)
      
         Defendant: European Food Safety Authority (EFSA) (represented by: D. Detken and S. Gabbi, acting as Agents, and by G. Rusconi and O. Cesana, lawyers)
      
         Re:
      
      Application pursuant to Articles 278 and 279 TFEU seeking the suspension of the operation of EFSA Decision EFSA/LA/DEC/22911258/2020 of 28 January 2020 concerning the request for internal review of the decision relating to the applicant’s requests for confidential treatment of the conclusion on the peer review of the risk assessment of the active substance mancozeb.
      
         Operative part of the order
      
      
                  1.
               
               
                  The application for interim relief is dismissed.
               
            
                  2.
               
               
                  The order of 7 April 2020 made in Case T-162/20 R is cancelled.
               
            
                  3.
               
               
                  The costs are reserved.